Aim and Scope:
The Iranian Journal of Blood and Cancer (IJBC) is published quarterly in print and online and includes high quality manuscripts including basic and clinical investigations of blood disorders and malignant diseases and covers areas such as diagnosis, treatment, epidemiology, etiology, biology, and molecular aspects as well as clinical genetics of these diseases editor., as they affect children, adolescents, and adults. The IJBC also includes studies on transfusion medicine, hematopoietic stem cell transplantation, immunology, genetics, and gene-therapy. The journal accepts original papers, systematic reviews, case reports, brief reports and letters to the editor, and photo clinics.
The IJBC is being published since 2008 by the Iranian Pediatric Hematology and Oncology Society (IPHOS). The contents of the journal are freely available for readers and researchers and there is no publication or processing fee.
The IJBC has a scientific research rank and is indexed in Directory of Open Access Journals (DOAJ), Islamic World Science Center (ISC), Index COpernicus (IC), and Embase. It is also visible in the following databases: Magiran, IranMedex, ISC, Scientific Information Database (SID), Cambridge Scientific Abstracts (CSA) Academic Search Complete (ASC), Electronic Journals Library (EJB), CINAHL, GEOBASE, CABI, Global Health, Open-J-Gate, Excerpta Medica, and Google Scholar.
All Submission should be sent online via our online submission system. For further inquiries please email the journal directly. The IJBC benefits from editorial freedom. Our editorial policy is consistent with the principles of editorial independence presented by WAME.
Manuscripts should be sent through the on-line submission system. A submission code is allocated to each article as well as a short submission ID and all the future contacts should be based on this code or ID. The articles are primarily evaluated by our internal screeners who check the articles for any methodological flaws, format, and their compliance with the journal’s instructions. Through a double-blind review, the articles will be reviewed by at least two external (peer) reviewers. Their comments will be passed to the authors and their responses to the comments along with the reviewers’ comments will then be evaluated by the Editor-in-Chief, the Scientific Editor, and a final reviewer who can be a member of the Editorial Board. The final review process will be discussed in regular editorial board sessions and on the basis of the comments, and the journal’s scope, the Editors-in-Chief will decide which articles should be published.
The journal is a member of the Committee on Publication Ethics (COPE). COPE’s flowcharts and guidelines are approached in confronting any ethical misbehavior. The Journal also follows the guidelines mentioned in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals
issued by the International Committee of Medical Journal Editors (ICMJE)
The research that involves human beings (or animals) must adhere to the principles of the Declaration of Helsinki.
• Informed consent:
All patients and participants of the research should be thoroughly informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent from the participants or their legal guardians is necessary for any such studies. The Journal reserves the right to request the related documents.
Based on the newly released Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, by the ICMJE, “an Author” is generally considered to be someone who meets the following conditions 1, 2, 3, and 4.
1-Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2-Drafting the work or revising it critically for important intellectual content; AND
3-Final approval of the version to be published; AND
4-Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
• Conflict of Interest:
We request all the authors to inform us about any kinds of “Conflict of Interest” (such as financial, personal, political, or academic) that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through:
The authors are not allowed to utilize verbatim text of previously published papers or manuscripts submitted elsewhere.
If a manuscript contains any previous published image or text, it is the responsibility of the author to obtain authorization from copyright holders. The author is required to obtain and submit the written original permission letters for all copyrighted material used in his/her manuscripts.
The IJBC uses the COPE flowchart for retraction of a published article
to determine whether a published article should be retracted.
Author Consent Form:
All authors must sign an Author Consent Form and return this form via Email so that the journal can begin the article's evaluation process. You hereby warrant that “This article is an original work, has not been published before and is not being considered for publication elsewhere in its final form either in printed or electronic form”.
Type of Articles:
Original Articles: Should contain title page, abstract, keywords, introduction, materials and methods, results, discussion, conclusion, acknowledgment, references, tables, and figures, enumerated from the title page. The length of the text should be limited to 3000 words excluding the references and abstract.
Case Reports and Brief Reports: Should not exceed 1500 words. Both should include abstract, keywords, introduction, case presentation, discussion, conclusion acknowledgment, and references. Case reports might have 1 to 4 accompanying figures and/or tables but brief reports should not have more than one figure or table. Necessary documentations of the case(s) like pathology and laboratory test reports should be included in the submission package.
Clinical Trials: should contain patients’ informed consent and the approval of the ethics committee of the corresponding institution.
Review Articles: might be requested by the editor, but IJBC will also accept submitted reviews. Both solicited and unsolicited review articles are subjected to editorial review like the original papers.
Letters to the Editor: IJBC accepts letters to the editor. Letters should be less than 500 words. Letters might discuss articles published in the journal during the previous six months or other important aspects related to the field of hematology. Letters will undergo peer-review processing and will be edited for clarity.
Photo clinics: Figures that convey a significant medical point can also be accepted. Photo clinics should contain one or two high quality figures and a description of the figure no more than 500 words. 2-4 references should be included.
Cover letter should contain a statement that you will not resubmit your article to another journal until the reviewing process will be completed. Also please indicate whether the authors have published or submitted any related papers from the same study.
Title Page of the article should include 1) the title of the article; 2) authors’ names; 3) name of the institution where the work was done; 4) running title (short form of the main title presented on the top of pages); and 5) complete mailing address, telephone/fax numbers, and email address of the corresponding author. This page is unnumbered.
Abstract should be structured for original articles providing background/objective for the study, methods, results, and conclusion. It should not exceed 250 words altogether. Number this page as page 1.
Abstracts of other types of contributions should be non-structured providing the essential information.
When abstracting a review article a concise summary of the salient points should be addressed.
Preferably, abbreviations should not be mentioned in the abstract.
Keywords are used for indexing purposes; each article should provide three to five keywords selected from the Medical Subject Headings (MeSH).
Introduction should provide a context or background and specifies the purpose or research objective of the study or observation.
Method must indicate clearly the steps taken to acquire the information. Be sure that it includes only information that was available at the time the plan or protocol for the study was written. It should be detailed (including: controls, inclusion and exclusion criteria, etc) and may be separated into subsections. Repeating the details of standard techniques is best avoided.
For reports of randomized controlled trials, authors should refer to the CONSORT statement (http://www.consort-statement .org/). All randomized clinical trials should be registered in any international RCT registration centers approved by the WHO. For research conducted in Iran, it is advised to register at IRCT (www.irct.ir).
Reporting guidelines such as STROBE, STARD, and PRISMA would help you to produce high quality research and to provide all required information and evidence for related methodology. EQUATOR Network website would help you in using these guidelines.
The software used for statistical analysis and description of the actual method should be mentioned.
Results should be presented in chronological sequence in the text, table, and illustration. Organize the results according to their importance. They should result from your own study.
Tables and illustrations must be cited in order which they appear in the text; using Arabic numerals. Tables should be simple and should not duplicate information in the text of the paper. Figures should be provided only if they improve the article. For radiographic films, scans, and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, send the high resolution figures in jpeg or bitmap format. Color photographs, if found to improve the article, would be published at no extra-charge at the print version of the journal. Type or print out legends for illustrations on a separate page, and explain the internal scale and identify the method of staining in photomicrographs.
Discussion should emphasize the new and important aspects of the study and the conclusions that follow them. Possible mechanisms or explanations for these findings should be explored. The limitations of the study and the implications of the findings for future research or clinical practice should be explored.
Conclusion should state the final result that the author(s) has (have) reached. The results of other studies should not be stated in this section.
Supplementary Materials such as movie clips, questionnaires, etc may be published on the online version of the journal.
Any technical help, general, financial, and material support or contributions that need acknowledging but do not justify authorship, can be cited at the end of the text as Acknowledgments.
References should be complied numerically according to the order of citation in the text in the Vancouver style. The numbers of references should not preferably exceed 40 for original articles, 15 for brief, and 8 for case reports.
For the references credited to more than 6 authors please provide the name of the first six authors and represent the rest authors by the phrase “et al.”
For various references please refer to “the NLM style guide for authors, editors, and publishers”. (http://www.ncbi.nlm.nih.gov/books/NBK7256/)
Listed below are sample references.
• Gaydess A, Duysen E, Li Y, Gilman V, Kabanov A, Lockridge O, et al. Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system. Chem Biol Interact. 2010;187:295-8. doi: 10.1016/j.cbi.2010.01.005. PubMed PMID: 20060815; PubMed Central PMCID: PMC2998607.
• Javan S, Tabesh M. Action of carbon dioxide on pulmonary vasoconstriction. J Appl Physiol. In press 2005
• Guyton AC: Textbook of Medical Physiology. 8th ed. Philadelphia, PA, Saunders, 1996.
Chapter in Book:
• Young VR. The role of skeletal muscle in the regulation of protein metabolism. In Munro HN, editor: Mammalian protein metabolism. Vol 4. San Diego; Academic; 1970. p. 585-674.
Language and Style:
Contributions should be in either American or British English language. The text must be clear and concise, conforming to accepted standards of English style and usage. Non-native English speakers may be advised to seek professional help with the language.
All materials should be typed in double line spacing numbered pages. Abbreviations should be standard and used just in necessary cases, after complete explanations in the first usage. The editorial office reserves the right to edit the submitted manuscripts in order to comply with the journal’s style. In any case, the authors are responsible for the published material.
Correction of Errata:
The journal will publish an erratum when a factual error in a published item has been documented.
For further information please contact the Editorial Office: